Soru

Zorluk: KolayInfectious Disease Mechanisms

An infectious disease consultation is requested for a 54-year-old male patient currently receiving mechanical ventilation in the intensive care unit. He developed a new-onset fever and increased purulent endotracheal secretions on hospital day 7. A chest radiograph demonstrates a new right lower lobe infiltrate. Tracheal aspirate cultures grow *Klebsiella pneumoniae*. The antimicrobial susceptibility report is provided below:

Antimicrobial AgentInterpretation
AmpicillinResistant
CeftriaxoneResistant
CeftazidimeResistant
CefepimeSusceptible
ImipenemSusceptible

Based on the susceptibility profile, which of the following is the most likely molecular mechanism underlying this pathogen's resistance to third-generation cephalosporins?

  1. Hydrolysis of the cyclic amide bond by an acquired enzymeCevap
  2. B
    Structural modification of membrane-bound transpeptidases
  3. C
    Active transport of the medication out of the bacterial periplasm
  4. D
    Substitution of a terminal D-lactate for D-alanine in cell wall precursors
  5. E
    Covalent modification of the antimicrobial agent via acetylation

Cevap

The mechanism is the hydrolysis of the cyclic amide bond by an acquired enzyme (beta-lactamase production).
The patient is infected with an Extended-Spectrum Beta-Lactamase (ESBL) producing strain of *Klebsiella pneumoniae*, evidenced by resistance to third-generation cephalosporins but susceptibility to carbapenems. The fundamental mechanism of all beta-lactamases is the targeted hydrolysis of the beta-lactam ring (a cyclic amide bond) of the antibiotic, rendering it incapable of inhibiting bacterial cell wall synthesis.

Adım Adım Çözüm

1
Interpret the microbial susceptibility table.
The organism is resistant to first through third-generation cephalosporins (ceftriaxone, ceftazidime) but remains susceptible to carbapenems (imipenem) and fourth-generation cephalosporins (cefepime).
This specific susceptibility pattern in Klebsiella pneumoniae is the hallmark of Extended-Spectrum Beta-Lactamase (ESBL) production.
2
Identify the molecular mechanism of the recognized resistance pattern.
ESBLs are enzymes that biochemically cleave the beta-lactam ring.
The beta-lactam ring is a cyclic amide bond essential for the antibiotic's ability to bind transpeptidases. Cleaving it inactivates the drug.

Anahtar Kavram

Extended-spectrum beta-lactamases (ESBLs) produced by Gram-negative bacilli (like Klebsiella) confer resistance to most penicillins and cephalosporins by hydrolyzing the beta-lactam ring, requiring treatment with carbapenems.
Bu soruyu puanla